NexImmune, Inc.

NEXI · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$32,344-$62,506-$50,902-$29,866
Dep. & Amort.$1,025$995$870$619
Deferred Tax$0$0-$3,292$442
Stock-Based Comp.$3,554$5,870$5,980$1,217
Change in WC-$4,878$3,929$655-$89
Other Non-Cash$1,214$521$904$1,272
Operating Cash Flow-$31,430-$51,191-$45,785-$26,405
Investing Activities
PP&E Inv.-$49-$1,255-$2,350-$865
Net Acquisitions$0$81-$32,065$0
Inv. Purchases$0-$21,510-$90,457$0
Inv. Sales/Matur.$0$73,000$39,000$1,006
Other Inv. Act.$4$0$32,065$80
Investing Cash Flow-$44$50,316-$53,807$222
Financing Activities
Debt Repay.$0$0$9,019$22,442
Stock Issued$0$5,145$114,722$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$33$1,147-$364
Financing Cash Flow$0$5,179$124,888$22,085
Forex Effect$0$0$0$0
Net Chg. in Cash-$31,475$4,303$25,295-$4,098
Supplemental Information
Beg. Cash$34,697$30,394$5,099$9,196
End Cash$3,222$34,697$30,394$5,099
Free Cash Flow-$31,479-$52,446-$48,135-$27,269